The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Tch Vct Regulatory News (AATG)

Share Price Information for Albion. Tch Vct (AATG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 67.50
Ask: 70.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.444%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
AATG Live PriceLast checked at -
Albion Technology & General VCT is an Investment Trust

To provide investors with a regular dividend income, combined with the prospect of long-term capital growth, through a balanced portfolio of unquoted growth and technology businesses in a qualifying VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Technology & General VCT PLC - Ordinary Shares : Interim Management Statement

15 Nov 2018 13:16



Albion Technology & General VCT PLC - Ordinary Shares : Interim Management Statement

Albion Technology & General VCT PLC Interim Management StatementLEI code: 213800TKJUY376H3KN16

IntroductionI am pleased to present Albion Technology & General VCT PLC (the “Company”)’s interim management statement for the period from 1 July 2018 to 30 September 2018.

Performance and dividendsThe Company’s unaudited net asset value (NAV) as at 30 September 2018 was £80.6 million or 77.9 pence per share (excluding treasury shares), an increase of 2 pence per share or 2.6 per cent. since 30 June 2018 (75.9 pence per share) as a result of an increase in investment valuations.

A second dividend for the year ending 31 December 2018 of 2.0 pence per Ordinary share is to be paid on 31 December 2018 to shareholders on the register on 7 December 2018, resulting in total dividends of 4.0 pence per share for the year.

Albion VCTs Prospectus Top Up Offers 2018/19The Company announced on 6 November 2018 that, subject to obtaining the requisite regulatory approval, it is the Company’s intention to launch a prospectus top up offer to raise up to £6 million before issue costs, with a further over-allotment facility of £2 million, of new Ordinary shares for subscription in the 2018/19 and 2019/20 tax years. Full details of the offer will be contained in a prospectus that is expected to be published in early January 2019.

Share buy-backsDuring the period from 1 July 2018 to 30 September 2018, the Company purchased 138,000 shares for £97,000 at an average price of 69.69 pence per share. All of the shares are to be held in treasury.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to the most recently announced net asset value, so far as market conditions and liquidity permit.

PortfolioThe following investments have been made during the period from 1 July 2018 to 30 September 2018:

New investments£000’sActivity
Phrasee Limited392AI platform that generates optimised marketing campaigns
Arecor Limited176Development of biopharmaceuticals through the application of a formulation technology platform
Forward Clinical Limited170A secure mobile communication and collaboration platform in healthcare
ePatient Network Limited115Online community connecting people affected by rare diseases with up-to-date scientific information, community insights and medical research
Total new investments853 

Follow-on investments£000’sActivity
Locum’s Nest Limited540Provides a technology solution for the management of locum doctors for the NHS
Quantexa Limited438Network analytics platform to detect financial crime
Total follow-on investments978 

Disposals

The following disposals were made during the period from 1 July 2018 to 30 September 2018:

Portfolio company£000’s 
sparesFinder Limited864Gain on opening value of £6,000
CSS Group Limited60Loss on opening value £119,000
Total proceeds924 

Top ten holdings as at 30 September 2018:

InvestmentCarrying value£000’s% of net asset valueActivity
Radnor House School (Holdings) Limited11,52114.3Independent schools for children aged 5-18
Process Systems Enterprise Limited4,9526.2Process modelling software and services
Chonais River Hydro Limited4,1725.2Owner and operator of a 2 MW hydro-power scheme in the Scottish Highland
Bravo Inns II Limited3,3334.2Owner and operator of freehold pubs
Quantexa Limited3,2024.0Network analytics platform to detect financial crime
Earnside Energy Limited2,3322.9Anaerobic digestion and composting plant located in Scotland
G.Network Communications Limited2,2182.8Ultra-fast fibre optic broadband provider in central London
Gharagain River Hydro Limited2,2142.8Owner and operator of a 1 MW hydroelectricity plant in the Scottish Highland
Mirada Medical Limited2,1752.7Developer of medical imaging software
memsstar Limited1,8882.4Refurbisher and manufacturer of MEMS and semiconductor fabrication equipment

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AATG, by following the ‘Portfolio of Investments’ link under the ‘Fund reports’ section.

Material events and transactions after the period end

Portfolio

After the period end, the Company had the following material investment transactions:

Disposal of Infinite Ventures (Goathill) Limited for £567,000 of which £14,000 is deferred and held in escrow; and Investment of £121,000 in an existing portfolio company, Cisiv Limited, which develops software and services for non-interventional clinical trials.

Further informationFurther information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AATG.

Dr. Neil Cross, Chairman15 November 2018For further information please contact:Patrick Reeve, Albion Capital Group LLP – tel: 020 7601 1850


Date   Source Headline
31st Dec 20187:00 amGNWDirector/PDMR Shareholding
31st Dec 20187:00 amGNWDirector/PDMR Shareholding
31st Dec 20187:00 amGNWDirector/PDMR Shareholding
13th Dec 20184:04 pmGNWTransaction in Own Shares
6th Dec 20181:08 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
30th Nov 201811:40 amGNWTotal voting rights and Capital
19th Nov 20183:09 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
15th Nov 20181:16 pmGNWAlbion Technology & General VCT PLC - Ordinary Shares : Interim Management Statement
6th Nov 20187:00 amGNWStatement regarding the proposed issue of a prospectus
31st Oct 20181:02 pmGNWTotal voting rights and Capital
31st Oct 201812:29 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
7th Aug 20095:01 pmRNSFinsbury Worldwide Pharmaceutical Trust PLC
7th Aug 20094:39 pmRNSAppointment of Director
7th Aug 20093:58 pmPRNNet Asset Value(s)
25th Mar 20093:28 pmRNSChange of Name
20th Mar 200911:01 amRNSFSA Document viewing facility
27th Feb 20093:02 pmRNSTotal Voting Rights
30th Jan 20094:04 pmRNSTotal Voting Rights
23rd Jan 200912:05 pmRNSChange of Inv Manager & Proposed Change of name
31st Dec 200810:41 amRNSTotal Voting Rights
30th Dec 20089:53 amRNSIssue of Equity
23rd Dec 20084:35 pmRNSTransaction in Own Shares
9th Dec 20083:22 pmRNSNet Asset Value(s)
8th Dec 200810:26 amRNSDoc re. Dividend
4th Dec 20089:49 amRNSDividend Declaration
3rd Dec 20082:43 pmRNSTransaction in Own Shares
2nd Dec 20085:04 pmRNSTransaction in Own Shares
28th Nov 20084:30 pmRNSTotal Voting Rights
19th Nov 20084:47 pmRNSDirector/PDMR Shareholding
3rd Nov 20082:58 pmRNSInterim Management Statement
31st Oct 20084:36 pmRNSTotal Voting Rights
3rd Oct 20089:28 amRNSIssue of Equity
30th Sep 20085:03 pmRNSTotal Voting Rights
16th Sep 20085:27 pmRNSTransaction in Own Shares
3rd Sep 20084:34 pmRNSTransaction in Own Shares
29th Aug 20083:32 pmRNSTotal Voting Rights
26th Aug 20082:57 pmRNSFSA document viewing facility
21st Aug 20086:28 pmRNSInterim Results
31st Jul 20085:08 pmRNSTotal Voting Rights
30th Jun 20085:47 pmRNSTotal Voting Rights
19th Jun 200812:24 pmRNSDirector/PDMR Shareholding
5th Jun 20083:34 pmRNSTransaction in Own Shares
5th Jun 20083:34 pmRNSIssue of Equity
30th May 20082:32 pmRNSIssue of Equity
16th May 200810:31 amRNSInterim Management Statement
30th Apr 20085:09 pmRNSTotal Voting Rights
25th Apr 20083:30 pmRNSTransaction in Own Shares
22nd Apr 20086:13 pmRNSAnnual Information Update
22nd Apr 20086:09 pmRNSDoc re. FSA Viewing Facility
18th Apr 20084:42 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.